Willamette Valley Pie Company Raspberry Rhubarb Pie, packaged in clamshells container, six containers per case. Each pie weighs 10 oz. a...
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0969-2020.
Raspberry Rhubarb Pie packages were recalled due to undeclared artificial almond. The actual product inside a clamshell package is Cherry Pie, which contains artificial almond extract, but it was mislabeled as Raspberry Rhubarb Pie. The Rhubarb Pie label does not declare artificial almond extract.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0969-2020.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Willamette Valley Pie Company, Llc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0969-2020.
Willamette Valley Pie Company, LLC.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Willamette Valley Pie Company, Llc. Recall FAQ
Willamette Valley Pie Company, Llc. is the subject of a beverages safety report: Willamette Valley Pie Company Raspberry Rhubarb Pie, packaged in clamshells container, six containers per case. Each pie weighs 10 oz. a.... The notice was published on May 13, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 48 units are potentially affected.